Trial NCT02806960

View at ClinicalTrials.gov 
Org. Study IDs: 16493
Secondary IDs: AMG-P4-459 AMG110 I8R-MC-IGBH

Last trial update was posted on 2019-12-13

MeSH Interventions

Glucagon

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Other Conditions


Stopping Reasons

Drug delivery was below target dose due to partial obstruction by aggregated particles.

Limitations And Caveats

The study drug was discovered to be delivering a potential sub-target dosing to some participants, due to partial obstruction of the delivery device by aggregation of particles. The study was terminated early with no safety concern for participants.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID